44 / 45
44
contraindications to plasma exchange: 3 days
versus 6 days. J Neurol Neurosurg Psychiatry
2001;71:235-8.
10.
Khan F, Pallant JF, Amatya B, Ng L, Gorelik A,
Brand C. Outcomes of high- and low-intensity
rehabilitation programme for persons in chronic
phase after Guillain-Barré syndrome: a randomized
controlled trial. J Rehabil Med 2011;43:638-46.
11.
Uchôa-Figueiredo LR, Negrini SB. Terapia
ocupacional: diferentes práticas em hospital geral.
Ribeirão Preto: Legis Summa; 2009.
12.
Atkinson SB, Carr RL, Maybee P, Haynes D. The
challenges of managing and treating Guillain-Barré
syndrome during the acute phase. Dimens Crit
Care Nurs 2006;25:256-63.
13.
Jamshidi N, Rostami M, Najarian S, Menhaj MB,
Saadatnia M, Firooz S. Modelling of human
walking to optimise the function of ankle-foot
orthosis in Guillan-Barré patients with drop foot.
Singapore Med J 2009;50:412-7.
14.
Cazeiro APM, Bastos SM, Santos EA, Almeida
MVM, Chagas JNM. A terapia ocupacional e as
atividades de vida diária, atividades instrumentais
da vida diária e tecnologia assistiva. Fortaleza:
ABRATO; 2011.
15.
Tripathi M, Kaushik S. Carbamezapine for pain
management in Guillain-Barré syndrome patients
in the intensive care unit. Crit Care Med.
2000;28:655-8.
16.
Pandey CK, Bose N, Garg G, Singh N, Baronia A,
Agarwal A, et al. Gabapentin for the treatment of
pain in guillain-barré syndrome: a double-blinded,
placebo-controlled, crossover study. Anesth Analg
2002;95:1719-23.